Compare PLUR & BCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PLUR | BCG |
|---|---|---|
| Founded | 2001 | 2016 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.9M | 39.8M |
| IPO Year | 2001 | N/A |
| Metric | PLUR | BCG |
|---|---|---|
| Price | $3.35 | $2.39 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 5.5K | 3.3K |
| Earning Date | 05-12-2026 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,336,000.00 | N/A |
| Revenue This Year | $97.38 | N/A |
| Revenue Next Year | $293.97 | N/A |
| P/E Ratio | ★ N/A | $56.15 |
| Revenue Growth | ★ 309.82 | N/A |
| 52 Week Low | $2.82 | $1.36 |
| 52 Week High | $7.13 | $3.44 |
| Indicator | PLUR | BCG |
|---|---|---|
| Relative Strength Index (RSI) | 51.18 | 61.56 |
| Support Level | $3.06 | $1.94 |
| Resistance Level | $3.50 | $2.45 |
| Average True Range (ATR) | 0.15 | 0.13 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 69.39 | 39.86 |
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.